Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition

BACKGROUND: Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by the hallmark finding of cerebral amyloid deposition. Many researchers have tried to predict the existence of cerebral amyloid deposition by using easily accessible blood plasma samples, but the effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jong-Chan, Jung, Keum Sim, Kim, Jiyeong, Jang, Ji Sung, Kwon, Sunghoon, Byun, Min Soo, Yi, Dahyun, Byeon, Gihwan, Jung, Gijung, Kim, Yu Kyeong, Lee, Dong Young, Han, Sun-Ho, Mook-Jung, Inhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786945/
https://www.ncbi.nlm.nih.gov/pubmed/33407839
http://dx.doi.org/10.1186/s13195-020-00751-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786945/
https://www.ncbi.nlm.nih.gov/pubmed/33407839
http://dx.doi.org/10.1186/s13195-020-00751-x

Ejemplares similares